1 completed, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Metastatic Disease: new trials by email Literature Review of Metastatic Disease trials Research Report on Metastatic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients Melanoma vaccine modified to express HLA A2/4-1BB ligand - High Risk HLA-A2+ Melanoma, Metastatic Disease | Phase 2 / Phase 3 | Withdrawn | Hadassah Medical Organization | 2017-03-01 | 2025-10-02 | |
| Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors donepezil hydrochloride, Placebo - Brain Tumors, Metastatic Disease | Phase 3 | Completed | Wake Forest University Health Sciences | 198 | 2008-02-01 | 2021-10-20 |
Neoplasm Metastasis (2) · Astrocytoma (1) · Brain Neoplasms (1) · Choroid Plexus Neoplasms (1) · Craniopharyngioma (1) · Ependymoma (1) · Fatigue (1) · Glioblastoma (1) · Glioma (1) · Glioma, Subependymal (1) · Gliosarcoma (1) · Medulloblastoma (1) · Melanoma (1) · Meningioma (1) · Neuroectodermal Tumors, Primitive (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neoplastic Processes (2) · Neuroectodermal Tumors (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Cerebral Ventricle Neoplasms (1) · Meningeal Neoplasms (1) · Neoplasms, Glandular and Epithelial (1)
Donepezil (1)
Hadassah Medical Organization (1) · Wake Forest University Health Sciences (1)
United States (1)
U10CA081851 (1)